Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells
Sign Up to like & getrecommendations! Published in 2020 at "FEBS Open Bio"
DOI: 10.1002/2211-5463.12985
Abstract: Malignant mesothelioma (MM) is an aggressive malignant neoplasm which rapidly invades pleural tissues and has a poor prognosis. Here, we explore enhancement of the effect of irinotecan [camptothecin‐11 (CPT‐11)] by the p53‐dependent induction of carboxylesterase… read more here.
Keywords: use irinotecan; cpt; mesothelioma; p53 ... See more keywords